19-49878558-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024682.3(TBC1D17):c.181C>A(p.Leu61Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024682.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D17 | NM_024682.3 | c.181C>A | p.Leu61Ile | missense_variant | 3/17 | ENST00000221543.10 | NP_078958.2 | |
TBC1D17 | NM_001168222.2 | c.82C>A | p.Leu28Ile | missense_variant | 2/16 | NP_001161694.1 | ||
TBC1D17 | XM_047439444.1 | c.181C>A | p.Leu61Ile | missense_variant | 3/16 | XP_047295400.1 | ||
TBC1D17 | XM_011527317.4 | c.181C>A | p.Leu61Ile | missense_variant | 3/14 | XP_011525619.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D17 | ENST00000221543.10 | c.181C>A | p.Leu61Ile | missense_variant | 3/17 | 1 | NM_024682.3 | ENSP00000221543.4 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251388Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135900
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461794Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727188
GnomAD4 genome AF: 0.000341 AC: 52AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.181C>A (p.L61I) alteration is located in exon 3 (coding exon 3) of the TBC1D17 gene. This alteration results from a C to A substitution at nucleotide position 181, causing the leucine (L) at amino acid position 61 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at